Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Change in Account Payables (2018 - 2025)

TransMedics has reported Change in Account Payables over the past 8 years, most recently at -$2.1 million for Q4 2025.

  • Quarterly results put Change in Account Payables at -$2.1 million for Q4 2025, up 34.23% from a year ago — trailing twelve months through Dec 2025 was -$19000.0 (up 98.64% YoY), and the annual figure for FY2025 was -$19000.0, up 98.64%.
  • Change in Account Payables for Q4 2025 was -$2.1 million at TransMedics, down from $2.5 million in the prior quarter.
  • Over the last five years, Change in Account Payables for TMDX hit a ceiling of $3.9 million in Q4 2021 and a floor of -$4.0 million in Q1 2022.
  • Median Change in Account Payables over the past 5 years was $352000.0 (2021), compared with a mean of $368100.0.
  • Biggest five-year swings in Change in Account Payables: plummeted 4793.9% in 2022 and later soared 6919.44% in 2025.
  • TransMedics' Change in Account Payables stood at $3.9 million in 2021, then tumbled by 93.17% to $264000.0 in 2022, then skyrocketed by 57.58% to $416000.0 in 2023, then tumbled by 854.33% to -$3.1 million in 2024, then surged by 34.23% to -$2.1 million in 2025.
  • The last three reported values for Change in Account Payables were -$2.1 million (Q4 2025), $2.5 million (Q3 2025), and -$1.2 million (Q2 2025) per Business Quant data.